May 1st, 2012
Weed through the guidance to properly append this commonly confused modifier. By G.J. Verhovshek, MA, CPC, and Rita Von Holtum, CPC-H Nearly 18 months since its introduction at the American Medical Association’s (AMA’s) 2010 CPT® Symposium, modifier 33 Preventive service continues to cause confusion. Here, we review eight quick tips that teach you when and ...
Apr 1st, 2011
The U.S. Food and Drug Administration (FDA) approved, March 24, the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in people 50 to 59 years of age. Zostavax, manufactured by Merck & Co. Inc., is already approved for use in people 60 years of age and older. Shingles affects approximately ...